Evidence map›Paper›PMID 36466012›Full record

ArticleFrontiers in reproductive health2022

Oncofertility care and influencing factors among cancer patients of reproductive age from Saudi Arabia.

Atlal Abusanad, Aseel Mohamed A Mokhtar, Saad Adel A Aljehani, Khaild Fuad A Aljuhani, Khalid Abdullah A Saleh, Baraa Hameed Alsubhi, Raad Mohammed Hamdi, Ammar Dawood Alzoriri

Open access · goldAbstract read
In one paragraph

Article in Frontiers in reproductive health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Atlal AbusanadMedical Oncology, King Abdul Aziz University Hospital, Jeddah, Makkah, Saudi Arabia.
Aseel Mohamed A MokhtarFaculty of Medicine, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia.
Saad Adel A AljehaniFaculty of Medicine, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia.
Khaild Fuad A AljuhaniFaculty of Medicine, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia.
Khalid Abdullah A SalehFaculty of Medicine, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia.
Baraa Hameed AlsubhiFaculty of Medicine, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia.
Raad Mohammed HamdiFaculty of Medicine, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia.
Ammar Dawood AlzoririFaculty of Medicine, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia.
King Abdulaziz University · SAKing Abdul Aziz University Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: More cancer survivors and a greater burden of long-term side effects have resulted from rising cancer incidence, improved treatment modalities, and younger age at cancer diagnosis. Treatment- related Infertility (TRI) is a well-known sequelae. This study looked at current oncofertility support and fertility preservation (FP) in men and women of reproductive age with cancer in Saudi Arabia, where there is little knowledge on the subject. Methods: A cross-sectional study included oncology patients of reproductive age from an academic hospital was conducted. Patients' characteristics, cancer type, treatment modalities and assessment of oncofertility support data were collected and examined to assess oncofertility support and potentially influencing factors. Results: Our study included 135 patients (39.3% males and 60.7% females). Although 66.7% believed they were fertile at the time of diagnosis, and more than half planned to have children in the future, Unfortunately, only 37.8% have received fertility counseling, and only 17% have seen a fertility specialist. In male patients, the most common FP method was sperm cryopreservation (6.7%), while the majority of both genders (87.4%) did not use any FP method. Two-thirds of the patients are knowledgeable about TRI and FP methods. About half of the female patients (57.3%) were advised about the possibility of post-treatment amenorrhea while only 8.1% of the whole cohort received psychological support. Conclusions: Despite patients' satisfactory knowledge of TRI and FP, oncologists infrequently referred their patients to a specialized fertility service. More than half of our patients expressed a desire to have children in the future, but this desire was impeded by limited oncofertility care and FP procedures. Several factors influenced the knowledge of TRI, fertility counseling and FP. It is critical to incorporate oncofertility into management planning as it has a significant impact on patients' quality of life.

Indexed as

cancerchemothearpycompetency frameworkdecision makingfertilityfertility preservationgonadotoxicityoncofertility

Identifiers

PMID36466012
PMCPMC9714457
OpenAlexW4309603533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.